Quattro Advisors’s Colgate-Palmolive CL Stock Holding History

Quattro Advisors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-243	Closed	-$19.2K	–	139
2025 Q4	$19.2K	Buy	+243	New	+$19.1K	0.02%	180

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Quattro Advisors's CL Position: Q1 2026 in Review

Quattro Advisors sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 243 shares — an estimated $19.2K sold.

Quattro Advisors first reported a position in CL in Q4 2025 and held it in 1 quarter. The position peaked at $19.2K in Q4 2025. 1,959 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Quattro Advisors reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
Quattro Advisors sold 243 Colgate-Palmolive shares in Q1 2026, an estimated $19.2K.
Quattro Advisors first reported a position in Colgate-Palmolive in Q4 2025 and held it in 1 quarter.
Quattro Advisors's Colgate-Palmolive position peaked at $19.2K in Q4 2025.
1,959 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Quattro Advisors's 13F filing for Q1 2026, filed 15 May 2026.